Carolina Martínez-Laperche

5PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 13, 2024
Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy.

Ismael de la Iglesia-San Sebastián, Miguel López-Esteban, Mariana Bastos-Oreiro

|May 07, 2022
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.

Miren Vallejo, Paula Muñiz, Mi Kwon

|Dec 29, 2020
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia.

Diego Carbonell, Julia Suárez-González, María Chicano

|May 08, 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1.

Johanna M Eberhard, Mathieu Angin, Caroline Passaes

|Apr 04, 2017
Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.

Carolina Martínez-Laperche, Mi Kwon, Ana C Franco-Villegas

Pageof 1

Frequent Collaborators

2 joint publications

Diego Carbonell

1 joint publications

Johanna M Eberhard

1 joint publications

Mathieu Angin

1 joint publications

Caroline Passaes